Disease | Financial Buzz

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Pfizer BioNTech COVID-19 Vaccine Confirmed to Lower Incidence Rates in Individuals

Bryan Shin03/11/2021

3878

Pfizer Inc. (NYSE: PFE), The Israel Ministry of Health and BioNTech SE (NASDAQ: BNTX) reported evidence that demonstrates lower incidence rates of COVID-19 disease in individuals that are vaccinated...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: DermTech, Inc. (NYSE: DMTK) Rises on Agreement with Blue Cross Blue Shield of Texas

financial buzz02/11/2021

1562

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “DermTech, Inc. Rises Amid Agreement with Blue Cross Blue Shield of Texas“ DermTech, Inc. (NASDAQ: DMTK) surged over...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Aurinia Pharmaceuticals (NASDAQ: AUPH) Receives FDA Approval for LUPKYNIS

financial buzz01/25/2021

2249

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Aurinia Pharmaceuticals Receives FDA Approval for LUPKYNIS” Aurinia Pharmaceuticals (NASDAQ: AUPH) soared over 37% in premarket trading after...

Biotechnology Breaking News Healthcare Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Adamis Pharmaceuticals (NASDAQ: ADMP) IND Submission to FDA for Covid-19 Treatment

financial buzz01/20/2021

2166

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Adamis Pharmaceuticals Skyrockets Amid IND Submission to FDA for Covid-19 Treatment” Adamis Pharmaceuticals (NASDAQ: ADMP) shot up over...

Biotechnology Breaking News Healthcare Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: La Jolla Pharmaceutical (NASDAQ: LJPC) Announces Licensing Agreement with PAION AG

financial buzz01/12/202101/12/2021

2336

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “La Jolla Pharmaceutical Announces Exclusive Licensing Agreement with PAION AG” La Jolla Pharmaceutical Company (NASDAQ: LJPC) surged 50%...

Investing News Life Style Market News Medical Use Pharmaceutical The Market Buzz Your Environment

Eli Lilly Announces Positive Results for its Alzheimer’s Drug

Rebecca Urena01/11/202101/11/2021

2251

Eli Lilly (NYSE: LLY), an American pharmaceutical company, announced on Monday that its experimental Alzheimer’s drug donanemab has proven to slow the disease by about a third the rate...

Biotechnology Breaking News Healthcare Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Lexicon Pharmaceuticals (NASDAQ: LXRX) Rises Amid Positive Phase 3 Results

financial buzz11/17/202011/17/2020

16189

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Lexicon Pharmaceuticals Rises Amid Positive Phase 3 Results” Lexicon Pharmaceuticals (NASDAQ: LXRX) stock shot up 75% in premarket...

Biotechnology Breaking News Healthcare Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Five Prime Therapeutics (NASDAQ: FPRX) Shares Rise on Positive Cancer Trial Results

financial buzz11/11/2020

5002

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Five Prime Therapeutics Shares Rise on Positive Cancer Trial Results” Five Prime Therapeutics (NASDAQ: FPRX) shot up 321%...

Investing News Market News Technology The Market Buzz

Bayer Announces Acquisition of Asklepios BioPharmaceutical to Further Cell and Gene Therapy

Bryan Shin10/26/2020

7866

Bayer AG reported the acquisition of Asklepios BioPharmaceutical, Inc. to broaden innovation base in pre-clinical and clinical stage candidates for the treatment of neuromuscular, central nervous system, cardiovascular and...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

“The Buzz” Show: Vertex (NASDAQ: VRTX) Down 20% After Discontinuing VX-814 Study

financial buzz10/15/202010/15/2020

7889

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Vertex Down 20% After Discontinuing VX-814 Study” Vertex Pharmaceuticals (NASDAQ: VRTX) is down more than 20% from previous...

Tag: Disease

Pfizer BioNTech COVID-19 Vaccine Confirmed to Lower Incidence Rates in Individuals

“The Buzz” Show: DermTech, Inc. (NYSE: DMTK) Rises on Agreement with Blue Cross Blue Shield of Texas

“The Buzz” Show: Aurinia Pharmaceuticals (NASDAQ: AUPH) Receives FDA Approval for LUPKYNIS

“The Buzz” Show: Adamis Pharmaceuticals (NASDAQ: ADMP) IND Submission to FDA for Covid-19 Treatment

“The Buzz” Show: La Jolla Pharmaceutical (NASDAQ: LJPC) Announces Licensing Agreement with PAION AG

Eli Lilly Announces Positive Results for its Alzheimer’s Drug

“The Buzz” Show: Lexicon Pharmaceuticals (NASDAQ: LXRX) Rises Amid Positive Phase 3 Results

“The Buzz” Show: Five Prime Therapeutics (NASDAQ: FPRX) Shares Rise on Positive Cancer Trial Results

Bayer Announces Acquisition of Asklepios BioPharmaceutical to Further Cell and Gene Therapy

“The Buzz” Show: Vertex (NASDAQ: VRTX) Down 20% After Discontinuing VX-814 Study

ABOUT US

Tweets